Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges

Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges

<p>Abstract</p> <p>Background</p> <p>The porcine reproductive and respiratory syndrome virus (PRRSV) is a rapidly evolving pathogen of swine. At present, there is a high demand for safe and more effective vaccines that can be adapted regularly to emerging virus variants...

Full description

Bibliographic Details
Main Authors:	Geldhof Marc F, Vanhee Merijn, Van Breedam Wander, Van Doorsselaere Jan, Karniychuk Uladzimir U, Nauwynck Hans J
Format:	Article
Language:	English
Published:	BMC 2012-10-01
Series:	BMC Veterinary Research
Online Access:	http://www.biomedcentral.com/1746-6148/8/182

Similar Items

Pathogenesis and antigenic characterization of a new East European subtype 3 porcine reproductive and respiratory syndrome virus isolate
by: Saveleva Tamara A, et al.
Published: (2010-06-01)

Demonstration of microchimerism in pregnant sows and effects of congenital PRRSV infection
by: Karniychuk Uladzimir U, et al.
Published: (2012-03-01)

Maternal Autogenous Inactivated Virus Vaccination Boosts Immunity to PRRSV in Piglets
by: Andrew R. Kick, et al.
Published: (2021-01-01)

Characterization of a circulating PRRSV strain by means of random PCR cloning and full genome sequencing
by: Nauwynck Hans J, et al.
Published: (2011-04-01)

A porcine reproductive and respiratory syndrome virus (PRRSV)-specific IgM as a novel adjuvant for an inactivated PRRSV vaccine improves protection efficiency and enhances cell-mediated immunity against heterologous PRRSV challenge
by: Rui Chen, et al.
Published: (2022-08-01)

Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine
by: Viravarn Luvira, et al.
Published: (2024-12-01)

Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
by: Otavio T. Ranzani, et al.
Published: (2022-10-01)

Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination
by: Noopur Bhatnagar, et al.
Published: (2023-07-01)

Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous <it>Mycoplasma hyopneumoniae </it>strains
by: Villarreal Iris, et al.
Published: (2012-01-01)

Protection of laying chickens against the Canadian DMV/1639 infectious bronchitis virus infection through priming with heterologous live vaccine and boosting with heterologous or homologous inactivated vaccine
by: Mohamed S.H. Hassan, et al.
Published: (2024-01-01)

Efficacy of a Modified Live Virus Vaccine against Porcine Reproductive and Respiratory Syndrome Virus 1 (PRRSV-1) Administered to 1-Day-Old Piglets in Front of Heterologous PRRSV-1 Challenge
by: Heinrich Kreutzmann, et al.
Published: (2021-10-01)

Phenotypic Characterization of a Virulent PRRSV-1 Isolate in a Reproductive Model With and Without Prior Heterologous Modified Live PRRSV-1 Vaccination
by: Heinrich Kreutzmann, et al.
Published: (2022-04-01)

PRRSV Vaccine Strain-Induced Secretion of Extracellular ISG15 Stimulates Porcine Alveolar Macrophage Antiviral Response against PRRSV
by: Hongbin Liu, et al.
Published: (2020-09-01)

Heterologous Challenge with PRRSV-1 MLV in Pregnant Vaccinated Gilts: Potential Risk on Health and Immunity of Piglets
by: Georgios Papakonstantinou, et al.
Published: (2022-02-01)

CpG-Recoding in Zika Virus Genome Causes Host-Age-Dependent Attenuation of Infection With Protection Against Lethal Heterologous Challenge in Mice
by: Ivan Trus, et al.
Published: (2020-01-01)

Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies
by: Xun Wang, et al.
Published: (2022-12-01)

Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants
by: Ruiqi Zhang, et al.
Published: (2022-01-01)

Follow-Up of PRRSv-Vaccinated Piglets Born from PRRSv-Vaccinated, ELISA-Seropositive and ELISA-Seronegative Sows
by: Jorian Fiers, et al.
Published: (2023-02-01)

Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study
by: Nasamon Wanlapakorn, et al.
Published: (2022-01-01)

Homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: Comment
by: Rujitika Mungmunpuntipantip, et al.
Published: (2023-08-01)

Selection and validation of reference genes for RT-qPCR normalization of porcine alveolar macrophages (PAMs) for PRRSV studies
by: Dayoung Oh, et al.
Published: (2023-05-01)

Heterologous Prime-Boost Vaccination with Commercial FMD Vaccines Elicits a Broader Immune Response than Homologous Prime-Boost Vaccination in Pigs
by: Jaejo Kim, et al.
Published: (2023-02-01)

Broad Protection of Pigs against Heterologous PRRSV Strains by a GP5-Mosaic DNA Vaccine Prime/GP5-Mosaic rVaccinia (VACV) Vaccine Boost
by: Junru Cui, et al.
Published: (2020-02-01)

Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
by: Andrew Chak-Yiu Lee, et al.
Published: (2021-08-01)

Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes.
by: Nya L Fraleigh, et al.
Published: (2019-01-01)

RNA-sequence analysis of primary alveolar macrophages after in vitro infection with porcine reproductive and respiratory syndrome virus strains of differing virulence.
by: Bouabid Badaoui, et al.
Published: (2014-01-01)

PRRSV-Vaccinated, Seronegative Sows and Maternally Derived Antibodies (II): Impact on PRRSV-1 Vaccine Effectiveness and Challenge Outcomes in Piglets
by: Jorian Fiers, et al.
Published: (2024-03-01)

The M/GP(5) glycoprotein complex of porcine reproductive and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-dependent manner.
by: Wander Van Breedam, et al.
Published: (2010-01-01)

Efficacy of the Synergy Between Live-Attenuated and Inactivated PRRSV Vaccines Against a NADC30-Like Strain of Porcine Reproductive and Respiratory Syndrome Virus in 4-Week Piglets
by: Chaosi Li, et al.
Published: (2022-02-01)

The Virosome as a Novel Concept for High Pathogenic Porcine Reproductive and Respiratory Syndrome Virus (HP-PRRSV) Vaccines
by: Zheng CAO, et al.
Published: (2013-07-01)

EFFECTS OF HOMOLOGOUS AND HETEROLOGOUS BOOSTER VACCINATIONS OF THE INACTIVATED DUAL-ADJUVANTED VACCINE VLA2001 AGAINST COVID-19 INCLUDING VARIANTS OF CONCERN: A PHASE 3 RANDOMIZED CLINICAL TRIAL
by: N. Wressnigg, et al.
Published: (2023-05-01)

Interaction of the European genotype porcine reproductive and respiratory syndrome virus (PRRSV) with sialoadhesin (CD169/Siglec-1) inhibits alveolar macrophage phagocytosis
by: De Baere Miet I, et al.
Published: (2012-05-01)

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine
by: Jialu Zhang, et al.
Published: (2021-01-01)

Systemic Homologous Neutralizing Antibodies Are Inadequate for the Evaluation of Vaccine Protective Efficacy against Coinfection by High Virulent PEDV and PRRSV
by: Ming Qiu, et al.
Published: (2022-04-01)

Improvement of inactivated vaccine against porcine reproductive respiratory syndrome
by: D. A. Biruchenkov, et al.
Published: (2018-04-01)

Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay
by: Chiara Orlandi, et al.
Published: (2023-05-01)

Efficacy of a Modified Live Porcine Reproductive and Respiratory Syndrome Virus 1 (PRRSV-1) Vaccine against Experimental Infection with PRRSV AUT15-33 in Weaned Piglets
by: Sophie Duerlinger, et al.
Published: (2022-06-01)

Comparing the SARS-CoV-2-specific antibody response in human milk after homologous and heterologous booster vaccinations
by: Sien J. Mulleners, et al.
Published: (2023-01-01)

The Effect of Inactivated Mycobacterium Paratuberculosis Vaccine on the Response to a Heterologous Bacterial Challenge in Pigs
by: Kristoffer Jarlov Jensen, et al.
Published: (2019-07-01)

Outcome of experimental porcine circovirus type 1 infections in mid-gestational porcine foetuses
by: Ducatelle Richard, et al.
Published: (2011-10-01)